YTRACIS

This brand name is authorized in Austria, Estonia, Spain, France, Israel, Lithuania, Poland, Singapore, United Kingdom

Active ingredients

The drug YTRACIS contains one active pharmaceutical ingredient (API):

1 Yttrium ⁹⁰Y chloride
UNII TN98A27Q17 - YTTRIUM CHLORIDE Y-90

Yttrium (90Y) chloride is produced by decay of its radioactive precursor Strontium (90Sr). It decays by emission of beta radiation of 2.281 MeV (99.98 %) of maximal energy to stable zirconium (90Zr). 90Y-yttrium has a half-life of 2.67 days (64.1 hours).

Read about Yttrium ⁹⁰Y chloride

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
YTRACIS Radiopharmaceutical precursor, solution European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V07AY Other non-therapeutic auxiliary products V Various → V07 All other non-therapeutic products → V07A All other non-therapeutic products
Discover more medicines within V07AY

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1208214
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 03250001
Country: FR Base de données publique des médicaments Identifier(s): 65491383
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 398576
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6748
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1029595
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100126560
Country: SG Health Sciences Authority Identifier(s): 13305P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.